AAAAAA

   
Results: 1-13 |
Results: 13
THE ROLE OF COST-CONSEQUENCE ANALYSIS IN HEALTH-CARE DECISION-MAKING
Authors: MAUSKOPF JA PAUL JE GRANT DM STERGACHIS A
Citation: Ja. Mauskopf et al., THE ROLE OF COST-CONSEQUENCE ANALYSIS IN HEALTH-CARE DECISION-MAKING, PharmacoEconomics, 13(3), 1998, pp. 277-288
COST-EFFECTIVENESS MODEL OF ADJUNCTIVE LAMOTRIGINE FOR THE TREATMENT OF EPILEPSY
Authors: MARKOWITZ MA MAUSKOPF JA HALPERN MT
Citation: Ma. Markowitz et al., COST-EFFECTIVENESS MODEL OF ADJUNCTIVE LAMOTRIGINE FOR THE TREATMENT OF EPILEPSY, Neurology, 51(4), 1998, pp. 1026-1033
COMPARISON OF VALACICLOVIR AND ACYCLOVIR FOR THE TREATMENT OF HERPES-ZOSTER IN IMMUNOCOMPETENT PATIENTS OVER 50 YEARS OF AGE - A COST-CONSEQUENCE MODEL
Authors: GRANT DM MAUSKOPF JA BELL L AUSTIN R
Citation: Dm. Grant et al., COMPARISON OF VALACICLOVIR AND ACYCLOVIR FOR THE TREATMENT OF HERPES-ZOSTER IN IMMUNOCOMPETENT PATIENTS OVER 50 YEARS OF AGE - A COST-CONSEQUENCE MODEL, Pharmacotherapy, 17(2), 1997, pp. 333-341
A COST-CONSEQUENCE MODEL COMPARING VALACICLOVIR AND ACYCLOVIR FOR THETREATMENT OF ACUTE HERPES-ZOSTER
Authors: GRANT DM MAUSKOPF JA AUSTIN R CHULAY JD BELL L
Citation: Dm. Grant et al., A COST-CONSEQUENCE MODEL COMPARING VALACICLOVIR AND ACYCLOVIR FOR THETREATMENT OF ACUTE HERPES-ZOSTER, Clinical infectious diseases, 23(4), 1996, pp. 108-108
INTERCOUNTRY DIFFERENCES IN HOSPITALIZATIONS OF PEOPLE WITH ADVANCED HIV-INFECTION (CD4-THAN 100 CELLS( LESS)MM(3))/
Authors: GRANT DM MAUSKOPF JA SAWYERR G
Citation: Dm. Grant et al., INTERCOUNTRY DIFFERENCES IN HOSPITALIZATIONS OF PEOPLE WITH ADVANCED HIV-INFECTION (CD4-THAN 100 CELLS( LESS)MM(3))/, AIDS, 10, 1996, pp. 107-107
FUNCTIONAL STATUS IN DEPRESSED-PATIENTS - THE RELATIONSHIP TO DISEASESEVERITY AND DISEASE RESOLUTION
Authors: MAUSKOPF JA SIMEON GP MILES MA WESTLUND RE DAVIDSON JRT
Citation: Ja. Mauskopf et al., FUNCTIONAL STATUS IN DEPRESSED-PATIENTS - THE RELATIONSHIP TO DISEASESEVERITY AND DISEASE RESOLUTION, The Journal of clinical psychiatry, 57(12), 1996, pp. 588-592
ECONOMIC-IMPACT OF TREATMENT OF HIV-POSITIVE PREGNANT-WOMEN AND THEIRNEWBORNS WITH ZIDOVUDINE - IMPLICATIONS FOR HIV SCREENING
Authors: MAUSKOPF JA PAUL JE WICHMAN DS WHITE AD TILSON HH
Citation: Ja. Mauskopf et al., ECONOMIC-IMPACT OF TREATMENT OF HIV-POSITIVE PREGNANT-WOMEN AND THEIRNEWBORNS WITH ZIDOVUDINE - IMPLICATIONS FOR HIV SCREENING, JAMA, the journal of the American Medical Association, 276(2), 1996, pp. 132-138
ESTIMATING THE DOLLAR VALUE OF HEALTH OUTCOMES FROM DRUG-ABUSE INTERVENTIONS
Authors: FRENCH MT MAUSKOPF JA TEAGUE JL ROLAND EJ
Citation: Mt. French et al., ESTIMATING THE DOLLAR VALUE OF HEALTH OUTCOMES FROM DRUG-ABUSE INTERVENTIONS, Medical care, 34(9), 1996, pp. 890-910
COST-CONSEQUENCE MODELS FOR VARICELLA-ZOSTER VIRUS-INFECTIONS
Authors: PAUL JE MAUSKOPF JA BELL L
Citation: Je. Paul et al., COST-CONSEQUENCE MODELS FOR VARICELLA-ZOSTER VIRUS-INFECTIONS, Pharmacotherapy, 15(5), 1995, pp. 49-58
ESTIMATING THE VALUE OF A GENERIC QUALITY-OF-LIFE MEASURE
Authors: MAUSKOPF JA AUSTIN R DIX LP BERZON RA
Citation: Ja. Mauskopf et al., ESTIMATING THE VALUE OF A GENERIC QUALITY-OF-LIFE MEASURE, Medical care, 33(4), 1995, pp. 195-202
SYNTHETIC SURFACTANT FOR RESCUE TREATMENT OF RESPIRATORY-DISTRESS-SYNDROME IN PREMATURE-INFANTS WEIGHING FROM 700 TO 1350 GRAMS - IMPACT ONHOSPITAL RESOURCE USE AND CHARGES
Authors: MAUSKOPF JA BACKHOUSE ME JONES D WOLD DE MAMMEL MC MULLETT M GUTHRIE R LONG WA
Citation: Ja. Mauskopf et al., SYNTHETIC SURFACTANT FOR RESCUE TREATMENT OF RESPIRATORY-DISTRESS-SYNDROME IN PREMATURE-INFANTS WEIGHING FROM 700 TO 1350 GRAMS - IMPACT ONHOSPITAL RESOURCE USE AND CHARGES, The Journal of pediatrics, 126(1), 1995, pp. 94-101
ECONOMIC OUTCOMES OF COLFOSCERIL PALMITATE RESCUE THERAPY IN INFANTS WEIGHING 1250G OR MORE WITH RESPIRATORY-DISTRESS SYNDROME - RESULTS FROM A RANDOMIZED TRIAL
Authors: BACKHOUSE ME MAUSKOPF JA JONES D WOLD DE SCHUMACHER R COTTON R LONG WA
Citation: Me. Backhouse et al., ECONOMIC OUTCOMES OF COLFOSCERIL PALMITATE RESCUE THERAPY IN INFANTS WEIGHING 1250G OR MORE WITH RESPIRATORY-DISTRESS SYNDROME - RESULTS FROM A RANDOMIZED TRIAL, PharmacoEconomics, 6(4), 1994, pp. 358-369
POTENTIAL HEALTH BENEFITS OF NUTRITION LABEL CHANGES
Authors: ZARKIN GA DEAN N MAUSKOPF JA WILLIAMS R
Citation: Ga. Zarkin et al., POTENTIAL HEALTH BENEFITS OF NUTRITION LABEL CHANGES, American journal of public health, 83(5), 1993, pp. 717-724
Risultati: 1-13 |